Why Nordic Small-Caps Are Poised for a Powerful Comeback — And Why Smart Investors Are Buying Now

After years of underperformance, Nordic small-cap companies are trading at historically attractive valuations — and one of the region’s most astute microcap investors believes we’re standing at the precipice of a major market rotation.

Matilda Karlsson, Portfolio Manager at Gaia Microcap, isn’t just betting on small companies — she’s doubling down. While institutional money continues to flock toward mega-caps perceived as “safe havens,” Karlsson and her team are quietly building concentrated positions in high-quality Nordic small-caps — firms with market caps between SEK 0.5 billion and SEK 10 billion — that have been unfairly punished by macro headwinds.

“This is the most compelling buying opportunity we’ve seen all year,” Karlsson told Realtid TV. “When quality businesses trade at discounts to their historical valuations — not because their fundamentals have deteriorated, but because sentiment has turned — that’s when long-term outperformance is born.”

The Historical Edge: Small-Caps Have Outperformed — Dramatically

The data doesn’t lie. Since 2002, Nordic small-cap stocks have delivered a staggering 1,600% total return — more than triple the 500% return posted by large-cap peers over the same period. That’s an outperformance gap of 1,100 percentage points.

Yet over the past three years, the tide has turned. Rising inflation, aggressive rate hikes, and macro uncertainty have driven investors toward perceived stability — large, liquid names with global footprints. Small-caps, seen as riskier and less resilient, have been left behind.

Karlsson sees this as cyclical — not structural.

“We’ve moved from a ‘growth at any cost’ era fuelled by near-zero rates to a more discerning, risk-aware environment,” she explains. “Investors are applying higher risk premiums to smaller companies — even when their fundamentals remain strong. That disconnect creates opportunity.”

How Gaia Microcap Finds Hidden Champions

Gaia Microcap doesn’t chase momentum or speculative stories. The fund employs a rigorous, multi-layered screening process that begins with quantitative filters: market leadership, consistent high single- or double-digit revenue growth, profitability, and manageable debt levels.

Out of thousands of Nordic-listed companies, only about 150 make the initial cut.

“But screening is just step one,” Karlsson emphasizes. “Anyone can back test historical data. What matters is what lies ahead.”

The real edge comes from qualitative deep dives: assessing management quality, corporate culture, ownership alignment, and strategic vision. Gaia seeks “good to great” businesses — not just statistically cheap stocks.

“We invest in companies where leadership is aligned with long-term value creation, where culture drives execution, and where ownership has skin in the game,” Karlsson says.

Case Study: Harvia — Overreaction Meets Opportunity

Take Finnish sauna giant Harvia — a Gaia Microcap holding since Karlsson took the helm. When the company reported Q2 results showing a slowdown in U.S. growth — its key expansion market — shares tumbled on investor panic.

But Gaia saw nuance where others saw failure.

“Yes, macro headwinds hit the U.S. consumer in Q2,” Karlsson notes. “But Harvia still grew North American sales by 35% in H1. Demand for premium home wellness isn’t disappearing — it’s just pausing. We believe this is temporary, and the market overreacted.”

The fund increased its position.

 BioGaia: Transformation in Motion

Another cornerstone holding is BioGaia, the Swedish probiotics innovator undergoing a strategic pivot under new CEO Therese Agnew. The company is shifting from a distributor-heavy model to direct-to-consumer and direct-to-retailer sales — a move that’s pressuring near-term margins but promises higher profitability and control long-term.

The market has punished the transition — but Gaia sees conviction where others see risk.

In August, the company’s newly appointed Chairman invested SEK 85 million of his own capital into BioGaia shares — a powerful signal of confidence that didn’t go unnoticed by Karlsson’s team.

“When leadership puts their money where their mouth is, it tells you something the spreadsheets can’t,” she says.

The Inevitable Reversion: History Favors the Patient

Karlsson’s thesis rests on a simple, powerful premise: market cycles revert to the mean. The current divergence between large and small caps is extreme — and unsustainable.

“We’ve seen this movie before,” she says. “When macro fears recede, liquidity returns, or growth becomes scarce again, investors rediscover the alpha potential in small-caps. The valuation gap will close — and when it does, the outperformance will be significant.”

For Nordic investors seeking differentiated returns, the message is clear: the time to build exposure to high-quality small-caps is now — before the crowd returns.

Bottom Line: 

While the market chases safety in large caps, Gaia Microcap is planting flags in tomorrow’s Nordic champions. History, valuation, and fundamental analysis all point in one direction: small-caps are set to outperform again — and Matilda Karlsson is making sure her investors are positioned to benefit.

Disclosure: This article is for informational purposes only and does not constitute investment advice. Always conduct your own due diligence or consult a financial advisor before making investment decisions.

Nordic Business Journal — Illuminating the Future of Nordic Capital Markets.

Leave a Reply

Your email address will not be published. Required fields are marked *